BRATTLEBORO, Vt.—New research shows NutraGenesis’ AllerGuard Express provides respiratory wellness benefits in a fast-acting, experiential manner. (Food and Science Nutrition Journal. Jul 2014; Online. DOI: 10.1002/fsn3.147)
In the study, subjects were exposed to a mixture of outdoor and indoor allergens (including grass and tree pollen, dust mites and animal dander), and then immediately took two tablets of either AllerGuard Express or placebo when symptoms began to develop. The ability to breathe through their nose over the next two hours was determined at 15-minute intervals using a mechanical device for measuring their level of Peak Nasal Inspiratory Flow (PNIF). Subjects reported their subjective perceptions of how they felt in terms of allergy-related symptoms. After a washout period, the subjects repeated the testing using the alternative treatment.
Subjects experienced improved nasal breathing and an enhanced feeling of wellness throughout the evaluation period, beginning as soon as 15 minutes after consumption of AllerGuard Express. After 15 minutes, there was a 27.7 percent reduction in PNIF scores in the group taking AllerGuard Express and an improvement in allergy-related symptoms ranging from 12 to 30 percent. The symptom of runny nose in the AllerGuard group improved 60 percent compared to placebo by the end of the two-hour evaluation period. In the study, AllerGuard was highly bioavailable and well-tolerated.
Earlier this year, the U.S. Patent and Trademark Office issued NutraGenesis a patent covering its WellBody 365® nutraceutical ingredient, a combination of beta glucan and ashwagandha.